<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clinical use of echinacea</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clinical use of echinacea</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Clinical use of echinacea</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert B Saper, MD, MPH</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joann G Elmore, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Seres, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sara Swenson, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 10, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Echinacea species are commonly referred to as coneflowers, a group of native American wildflowers from the daisy family (Asteraceae/Compositae)  (<a class="graphic graphic_picture graphicRef71115" href="/z/d/graphic/71115.html" rel="external">picture 1</a>) [<a href="#rid1">1</a>]. Echinacea is indigenous to North America and was used by Native Americans of the Great Plains. Samples of echinacea have been found in archeologic digs from the 1600s, thought to be the location of Lakota Sioux village sites [<a href="#rid2">2</a>]. Native Americans used echinacea both topically and systemically for ailments such as burns, snakebites, pain, cough, and sore throat [<a href="#rid3">3</a>].</p><p>This topic will review the proposed clinical pharmacology of echinacea and clinical evidence addressing its efficacy, as well as precautions and contraindications to its use. A general discussion of herbal medications can be found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">"Overview of herbal medicine and dietary supplements"</a>.)</p><p class="headingAnchor" id="H314230054"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Echinacea is generally used with the intention of treating or preventing uncomplicated upper respiratory tract infections such as the common cold [<a href="#rid4">4</a>]. In 2012, echinacea was the sixth most common non-vitamin, non-mineral supplement used by adults in the United States, used by 2.3 million adults [<a href="#rid5">5</a>]. A National Health Interview Survey found that echinacea use decreased by approximately one-half from 2007 to 2012 [<a href="#rid6">6</a>]. Similarly, echinacea use by children fell from the most commonly used herbal product in 2007 to the fourth most common in 2012 [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">"Overview of herbal medicine and dietary supplements"</a> and  <a class="medical medical_review" href="/z/d/html/6868.html" rel="external">"The common cold in adults: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PROPOSED MECHANISMS OF ACTION</span><span class="headingEndMark"> — </span>Various echinacea species including <em>Echinacea purpurea</em>, <em>E. angustifolia</em>, and <em>E. pallida</em> have been touted as "immune stimulants" by a number of investigators [<a href="#rid7">7</a>]. Medicinal preparations using the root and above-ground parts of echinacea species have been the subject of in vitro, animal, and human studies to evaluate their possible mechanism(s), safety, and efficacy.</p><p>Echinacea products contain a variety of bioactive ingredients including echinacosides, caffeic acids, alkylamides, polysaccharides, and glycoproteins [<a href="#rid8">8</a>]. Though several echinacea products are standardized to the amount of echinacosides, there is no general consensus on the active component(s) of echinacea responsible for its purported medicinal properties.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>In vitro activity</strong> – Echinacea causes macrophage activation and the release of tumor necrosis factor, interleukin 1, interleukin 6, and interferon [<a href="#rid9">9-11</a>]. Echinacea has been noted to have antiviral activity against influenza [<a href="#rid12">12</a>] and herpes virus [<a href="#rid13">13</a>]. Phenolic compounds present in echinacea demonstrate antioxidant activity [<a href="#rid14">14</a>]. It has also been reported to have anti-inflammatory activity through inhibition of lipoxygenase and cyclooxygenase [<a href="#rid15">15</a>] and is able to stimulate the anterior pituitary-adrenal cortex.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>In vivo activity</strong> – In animal studies, echinacea affects several aspects of the immune system, in part by increasing the number of circulating white blood cells [<a href="#rid16">16</a>]. Echinacea also increases phagocytosis, promotes activity of lymphocytes, stimulates cytokine production, triggers the alternate complement pathway, and modulates apoptosis [<a href="#rid17">17,18</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h1">PROPOSED INDICATIONS AND CLINICAL TRIALS</span><span class="headingEndMark"> — </span>Many clinical studies have attempted to elucidate the safety and effectiveness of echinacea. This research is challenging because there are differing opinions regarding the optimal echinacea species, plant part(s), active component(s), and dose to study and studies have been small and of variable quality. Further, the specific echinacea products used in studies are often not standardized. However, meta-analysis of the available randomized, double-blind, placebo-controlled trials may be informative, particularly around the use of echinacea for upper respiratory tract infections (URI).</p><p class="headingAnchor" id="H4"><span class="h2">Upper respiratory tract infection</span><span class="headingEndMark"> — </span>Echinacea is commonly used by patients for the treatment and prevention of nonspecific URI.</p><p class="headingAnchor" id="H12395121"><span class="h3">Treatment</span><span class="headingEndMark"> — </span>In a 2014 systematic review including 15 randomized trials comparing various echinacea preparations with placebo, there was no benefit of echinacea for the treatment of viral URI [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H6"><span class="h3">Prevention</span><span class="headingEndMark"> — </span>Although echinacea may have a role in preventing community-acquired URIs, the certainty of evidence regarding its benefit is low, and the likely magnitude of reduction in cold incidence is small and offset by side effects. Well-designed, randomized trials have generally not shown statistically significant differences between echinacea preparations and placebo, but their small size limited precision [<a href="#rid4">4,20</a>]. In an exploratory meta-analysis of nine mostly low-quality trials, prophylactic echinacea reduced the number of participants with at least one cold episode (relative risk 0.83; 95% CI 0.75-0.92; I<sup>2</sup> = 0 percent; number needed to treat = 10) [<a href="#rid19">19,21</a>]. It is not clear if this difference is clinically meaningful to patients or if the quality of evidence is sufficient to support its use for this purpose. Moreover, adverse events occurred more frequently in those randomized to echinacea and most commonly included headache, nausea, and a bad taste.</p><p>A subsequent trial that randomized 201 asymptomatic children to Echinaforce (400 mg freshly harvested <em>E. purpurea</em> alcoholic extract) versus vitamin C (50 mg) found fewer URI episodes at four month follow-up in children randomized to echinacea (odds ratio 0.52; 95% CI 0.30-0.91) [<a href="#rid22">22</a>]. Children randomized to echinacea were also less likely to have any cold episodes (39 versus 55 percent), receive antibiotics (5.8 versus 13.5 percent), have URI-related complications (eg, pneumonia, otitis media, sinusitis), or have influenza detected (3 versus 20 detections, p = 0.012), compared with those assigned to vitamin C. Adverse events occurred slightly more frequently in those randomized to vitamin C. These findings await replication in larger clinical trials.</p><p class="headingAnchor" id="H7"><span class="h1">SAFETY CONSIDERATIONS</span></p><p class="headingAnchor" id="H8"><span class="h2">Adverse effects</span><span class="headingEndMark"> — </span>Although echinacea is generally well tolerated, side effects can occasionally occur. Allergic reactions can occur in individuals sensitive to the Asteraceae/Compositae family. Patients with allergies to ragweed, chrysanthemums, marigolds, and daisies may have dermatologic reactions to echinacea [<a href="#rid23">23</a>]. One trial found that rash was also more frequent in children treated with oral echinacea compared with placebo (7.1 versus 2.7 percent) [<a href="#rid24">24</a>].</p><p>A few case reports of anaphylaxis associated with use of <em>E. angustifolia</em> and <em>E. purpurea</em> have been published [<a href="#rid23">23,25</a>].</p><p class="headingAnchor" id="H3512551369"><span class="h2">Contraindications</span></p><p class="headingAnchor" id="H9"><span class="h3">Use in autoimmune disease</span><span class="headingEndMark"> — </span>The immune stimulating effects of echinacea have led to concerns regarding the use of echinacea in patients with autoimmune disorders [<a href="#rid1">1</a>]. Despite these concerns, little is known regarding the exacerbation of autoimmune illnesses due to echinacea. Case reports include an exacerbation of pemphigus vulgaris, a recurrence of erythema nodosum, and a case of renal tubular acidosis due to Sjögren's associated with echinacea use [<a href="#rid26">26-28</a>]. By contrast, a pilot study in patients with low-grade autoimmune idiopathic uveitis found that treatment with <em>E. purpurea</em> extract was associated with shorter duration of steroid treatment required to induce remission [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Use in pregnancy</span><span class="headingEndMark"> — </span>A cohort study followed pregnant individuals who contacted the Toronto Motherisk Program about gestational use of echinacea [<a href="#rid30">30</a>]. There were 206 people who used echinacea products in pregnancy (112 during the first trimester). No increased risk for still births, spontaneous abortions, and major fetal malformations occurred in those who used echinacea compared with 206 controls matched for age, alcohol use, and cigarette smoking. Similarly, the Norwegian Mother and Child Cohort Study identified 363 pregnant individuals reporting echinacea use with no associated increased risk of congenital fetal anomalies or poor pregnancy outcomes [<a href="#rid31">31</a>]. A systematic review also did not find evidence suggesting that echinacea is teratogenic [<a href="#rid32">32</a>]. Nonetheless, it is prudent to avoid echinacea during pregnancy and lactation.</p><p class="headingAnchor" id="H11"><span class="h1">HERB-DRUG INTERACTIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Because of its immunostimulating activity, echinacea may interfere with immunosuppressant therapy [<a href="#rid1">1</a>] and should be avoided in patients taking immunosuppressants.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is in vivo evidence that echinacea may effect CYP3A and CYP1A2 activities [<a href="#rid33">33</a>], although there are no reports of clinically significant adverse interactions in patients taking drugs metabolized by these enzymes. Nonetheless, caution should be advised in those taking such medications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one in vitro study, echinacea extracts stimulated the proliferation of cervical and breast cancer cells despite exposure to <a class="drug drug_general" data-topicid="9391" href="/z/d/drug information/9391.html" rel="external">doxorubicin</a> [<a href="#rid34">34</a>]. The clinical relevance of this potentially harmful interaction between echinacea and doxorubicin is not clear and requires further study.</p><p></p><p class="headingAnchor" id="H862247615"><span class="h1">ADMINISTRATION</span></p><p class="headingAnchor" id="H12"><span class="h2">Dose</span><span class="headingEndMark"> — </span>There is substantial product variation in species of echinacea, part of plant used, formulation, and extraction method, and thus doses are not standardized. Typical doses recommended by manufacturers and herbal experts and used in studies are 300 to 400 mg of dried extract taken orally three times daily, one cup of tea (1 gram root in 150 mL boiling water for 5 to 10 minutes) three times daily, and 0.25 to 1 mL of liquid alcohol extract three times daily [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H13"><span class="h2">Standardization</span><span class="headingEndMark"> — </span>Many different preparations of echinacea are available. Despite attempts by the US Food and Drug Administration (FDA) to improve regulation of quality and safety standards for dietary supplements [<a href="#rid35">35</a>], experts have criticized these standards as insufficient and enforcement activities as inadequate [<a href="#rid36">36,37</a>]. Until the effectiveness of these regulations has been confirmed, patients who choose to use echinacea can use products that have passed specified quality criteria by independent commercial laboratories. (See  <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">"Overview of herbal medicine and dietary supplements", section on 'Quality and efficacy'</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/4014.html" rel="external">"Patient education: The common cold in adults (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Not effective for the treatment of viral upper respiratory infections</strong> – Although echinacea may have some immune stimulating effects, the evidence does not support its efficacy in treating the common cold and we recommend not using it for this purpose (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Uncertain efficacy in preventing viral upper respiratory infections</strong> – We do not recommend for or against echinacea for prevention of upper respiratory tract infections. Although echinacea may have a weak effect on the prevention of colds and some of their complications, it requires taking a daily pill that can have side effects. (See <a class="local">'Prevention'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Safety</strong> – Echinacea appears to be relatively safe; although, allergic reactions and side effects of headache, nausea, and bad taste have been reported. (See <a class="local">'Safety considerations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Lack of standardization</strong> – As with other herbal preparations, variability of echinacea preparations is an obstacle to its potential use by patients and prescription by clinicians. (See <a class="local">'Standardization'</a> above and  <a class="medical medical_review" href="/z/d/html/1392.html" rel="external">"Overview of herbal medicine and dietary supplements"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Echinacea. In: Natural Medicines, Therapeutic Research Center Healthcare 2020. Available at: https://naturalmedicines.therapeuticresearch.com/ (Accessed on August 08, 2020).</li><li><a class="nounderline abstract_t">Wedel W. Bur Am Ethn Bull 1936; 112:59.</a></li><li class="breakAll">Bauer R, Wagner H. Echinacea: Handbuch Fur Arzte, Apotheker und andere Naturwissencraftler, Wissenschaftliche Vorlagsgesellschaft, 1990.</li><li><a class="nounderline abstract_t">Melchart D, Walther E, Linde K, et al. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med 1998; 7:541.</a></li><li class="breakAll">Black LI, Clarke TC, Barnes PM, et al. Use of complementary health approaches among children aged 4–17 years in the United States: National Health Interview Survey, 2007–2012. Centers for Disease Control and Prevention, 2015. https://stacks.cdc.gov/view/cdc/27597.</li><li class="breakAll">National Center for Complementary and Integrative Health. Trends in the use of complementary health approaches in the United States: 2002–2012. US Department of Health and Human Services 2012. Available at: https://www.nccih.nih.gov/research/trends-in-the-use-of-complementary-health-in-the-united-states-20022012 (Accessed on November 23, 2021).</li><li><a class="nounderline abstract_t">Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med 1999; 5:40.</a></li><li class="breakAll">Bauer R, Wagner H. Echinacea species as potential immunostimulatory drugs. In: Economic and Medicinal Plant Research, Wagner H (Ed), Academic Press, 1991. p.253.</li><li><a class="nounderline abstract_t">Braunig B, Dorn M, Limburg E, Knick E. Enhancement of resistance in common cold by Echinacea purpurea. Z Phytother 1992; 13:7.</a></li><li><a class="nounderline abstract_t">Hwang SA, Dasgupta A, Actor JK. Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts. Clin Chim Acta 2004; 343:161.</a></li><li><a class="nounderline abstract_t">Sullivan AM, Laba JG, Moore JA, Lee TD. Echinacea-induced macrophage activation. Immunopharmacol Immunotoxicol 2008; 30:553.</a></li><li><a class="nounderline abstract_t">Pleschka S, Stein M, Schoop R, Hudson JB. Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J 2009; 6:197.</a></li><li><a class="nounderline abstract_t">Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res 2009; 83:165.</a></li><li><a class="nounderline abstract_t">Pellati F, Benvenuti S, Magro L, et al. Analysis of phenolic compounds and radical scavenging activity of Echinacea spp. J Pharm Biomed Anal 2004; 35:289.</a></li><li><a class="nounderline abstract_t">Müller-Jakic B, Breu W, Pröbstle A, et al. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Med 1994; 60:37.</a></li><li><a class="nounderline abstract_t">Catanzaro M, Corsini E, Rosini M, et al. Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea. Molecules 2018; 23.</a></li><li><a class="nounderline abstract_t">Luettig B, Steinmüller C, Gifford GE, et al. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst 1989; 81:669.</a></li><li><a class="nounderline abstract_t">Di Carlo G, Nuzzo I, Capasso R, et al. Modulation of apoptosis in mice treated with Echinacea and St. John's wort. Pharmacol Res 2003; 48:273.</a></li><li><a class="nounderline abstract_t">Karsch-Völk M, Barrett B, Kiefer D, et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev 2014; :CD000530.</a></li><li><a class="nounderline abstract_t">Grimm W, Müller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999; 106:138.</a></li><li><a class="nounderline abstract_t">Karsch-Völk M, Barrett B, Linde K. Echinacea for preventing and treating the common cold. JAMA 2015; 313:618.</a></li><li><a class="nounderline abstract_t">Ogal M, Johnston SL, Klein P, Schoop R. Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial. Eur J Med Res 2021; 26:33.</a></li><li><a class="nounderline abstract_t">Hoban CL, Byard RW, Musgrave IF. Analysis of spontaneous adverse drug reactions to echinacea, valerian, black cohosh and ginkgo in Australia from 2000 to 2015. J Integr Med 2019; 17:338.</a></li><li><a class="nounderline abstract_t">Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA 2003; 290:2824.</a></li><li><a class="nounderline abstract_t">Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 1998; 168:170.</a></li><li><a class="nounderline abstract_t">Lee AN, Werth VP. Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch Dermatol 2004; 140:723.</a></li><li><a class="nounderline abstract_t">Soon SL, Crawford RI. Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol 2001; 44:298.</a></li><li><a class="nounderline abstract_t">Logan JL, Ahmed J. Critical hypokalemic renal tubular acidosis due to Sjögren's syndrome: association with the purported immune stimulant echinacea. Clin Rheumatol 2003; 22:158.</a></li><li><a class="nounderline abstract_t">Neri PG, Stagni E, Filippello M, et al. Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis: a pilot study. J Ocul Pharmacol Ther 2006; 22:431.</a></li><li><a class="nounderline abstract_t">Gallo M, Sarkar M, Au W, et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med 2000; 160:3141.</a></li><li><a class="nounderline abstract_t">Heitmann K, Havnen GC, Holst L, Nordeng H. Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study. Eur J Clin Pharmacol 2016; 72:623.</a></li><li><a class="nounderline abstract_t">Perri D, Dugoua JJ, Mills E, Koren G. Safety and efficacy of echinacea (Echinacea angustafolia, e. purpurea and e. pallida) during pregnancy and lactation. Can J Clin Pharmacol 2006; 13:e262.</a></li><li><a class="nounderline abstract_t">Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004; 75:89.</a></li><li><a class="nounderline abstract_t">Huntimer ED, Halaweish FT, Chase CC. Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity. Chem Biodivers 2006; 3:695.</a></li><li class="breakAll">US Food and Drug Administration. Statement from FDA Commissioner Scott Gottlieb, MD, on the agency’s new efforts to strengthen regulation of dietary supplements by modernizing and reforming FDA’s oversight. Available at: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-agencys-new-efforts-strengthen-regulation-dietary (Accessed on August 08, 2020).</li><li><a class="nounderline abstract_t">Cohen PA. Assessing supplement safety--the FDA's controversial proposal. N Engl J Med 2012; 366:389.</a></li><li><a class="nounderline abstract_t">The Lancet . Dietary supplement regulation: FDA's bitter pill. Lancet 2019; 393:718.</a></li></ol></div><div id="topicVersionRevision">Topic 1389 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://naturalmedicines.therapeuticresearch.com/" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Echinacea. In: Natural Medicines, Therapeutic Research Center Healthcare 2020. Available at: https://naturalmedicines.therapeuticresearch.com/ (Accessed on August 08, 2020).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : </p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : </p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9821828" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9821828" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9821828" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10394673" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Assessing the risks and benefits of herbal medicine: an overview of scientific evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10394673" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Assessing the risks and benefits of herbal medicine: an overview of scientific evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Enhancement of resistance in common cold by Echinacea purpurea</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15115689" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18618312" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Echinacea-induced macrophage activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19912623" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19409931" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15063463" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Analysis of phenolic compounds and radical scavenging activity of Echinacea spp.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8134414" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30373170" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Immunomodulators Inspired by Nature: A Review on Curcumin and Echinacea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2785214" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12860446" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Modulation of apoptosis in mice treated with Echinacea and St. John's wort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24554461" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Echinacea for preventing and treating the common cold.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10230741" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25668266" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Echinacea for preventing and treating the common cold.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33832544" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Echinacea reduces antibiotic usage in children through respiratory tract infection prevention: a randomized, blinded, controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31113761" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Analysis of spontaneous adverse drug reactions to echinacea, valerian, black cohosh and ginkgo in Australia from 2000 to 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14657066" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9507713" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Echinacea-associated anaphylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15210464" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Activation of autoimmunity following use of immunostimulatory herbal supplements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11174391" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Recurrent erythema nodosum associated with Echinacea herbal therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12740687" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Critical hypokalemic renal tubular acidosis due to Sjögren's syndrome: association with the purported immune stimulant echinacea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17238809" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11074744" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26895223" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pregnancy outcomes after prenatal exposure to echinacea: the Norwegian Mother and Child Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17085774" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Safety and efficacy of echinacea (Echinacea angustafolia, e. purpurea and e. pallida) during pregnancy and lactation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14749695" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17193302" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17193302" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Proliferative activity of Echinacea angustifolia root extracts on cancer cells: Interference with doxorubicin cytotoxicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22276780" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Assessing supplement safety--the FDA's controversial proposal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30799001" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Dietary supplement regulation: FDA's bitter pill.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
